Diagnosis: Erythema Infectiosum (Fifth Disease) Caused by Parvovirus B19
The correct answer is E (A + C): This is a Parvovirus B19 infection that infects early erythroid precursors in the bone marrow.
Clinical Reasoning
This 3-year-old presents with the classic triad of erythema infectiosum (fifth disease):
- "Slapped cheek" appearance (facial erythema 2 days prior)
- Reticular (lacy, net-like) rash on trunk and extremities
- Prodromal symptoms (nasal congestion, headache) preceding the rash
The sibling with identical self-limited symptoms strongly supports a contagious viral etiology, which is characteristic of Parvovirus B19 transmission through respiratory droplets 1.
Why Parvovirus B19?
The clinical presentation is pathognomonic for erythema infectiosum 2, 3:
- Stage 1: Facial erythema with "slapped cheek" appearance occurs first
- Stage 2: Diffuse reticular/lacy erythema spreads to trunk, extremities, and buttocks (typically sparing palms and soles)
- Stage 3: Evanescence and recrudescence over approximately 3 weeks
The reticular exanthem on the limbs is present in 100% of cases, while cheek exanthema occurs in approximately 90% 4. This lacy pattern helps distinguish erythema infectiosum from other viral exanthems 2.
Bone Marrow Tropism
Parvovirus B19 specifically infects early erythroid precursors in the bone marrow 2. This tropism explains:
- Why the virus causes transient aplastic crisis in patients with chronic hemolytic anemias
- The mechanism of hydrops fetalis in pregnant women
- Why immunocompromised patients can develop persistent anemia
This is NOT a lymphocyte precursor infection (ruling out option B), distinguishing it from viruses like EBV or CMV.
Why Not Coxsackievirus?
While coxsackievirus can cause maculopapular rashes 1, it does not produce:
- The characteristic "slapped cheek" appearance
- The distinctive reticular/lacy pattern on extremities
- The specific two-stage progression (facial → body rash)
Coxsackievirus typically causes hand-foot-mouth disease or nonspecific viral exanthems without this pathognomonic pattern.
Management Approach
Treatment is symptomatic and supportive 2:
- Reassurance that the condition is self-limited
- Antihistamines if pruritus present (occurs in ~50% of cases)
- No isolation needed once rash appears (patient no longer contagious)
- Monitor for complications in high-risk patients
Critical Caveats
When to worry about Parvovirus B19:
- Chronic hemolytic anemia (sickle cell, hereditary spherocytosis): Risk of transient aplastic crisis
- Immunocompromised patients: Risk of persistent infection and chronic anemia
- Pregnancy exposure: Risk of hydrops fetalis (requires maternal counseling)
- Arthralgia/arthritis: More common in adults than children
The diagnosis is primarily clinical 2, 3. Serologic testing (IgM/IgG) is reserved for atypical presentations, immunocompromised patients, pregnant exposures, or when complications develop.